Tata India Pharma & Healthcare Fund - Growth - Direct Plan

NAV 32.80(-1.08%)
Apr 01, 2025
Tata India Pharma & Healthcare Fund - Growth - Direct Plan
AUM
₹1,103 Cr
Expense (%)
0.74
Turnover (%)
9.96
Benchmark
NIFTY PHARMA - TRI
Asset Quality
Large, Green
Differs from benchmark (%)
95.11

3Yr Rolling Returns(%)

Benchmark# : undefined
                                                                                                                                                            Benchmark# is
Loading...

Top 10 Holdings

Something went wrong. Please try again after sometime!
PortfolioCompare

FAQ : Tata India Pharma & Healthcare Fund - Growth - Direct Plan

Tata India Pharma & Healthcare Fund - Growth - Direct Plan has delivered CAGR and average rolling returns as follows :

1 Year 3 Year 5 Year 9 Year
CAGR(%) 5.77 17.47 22.53 12.03
Average Rolling Returns(%) 17.88 15.43 17.16 11.77

The Current NAV of Tata India Pharma & Healthcare Fund - Growth - Direct Plan is ₹32.80.

You should look for a fund with better more consistent performance track record. Funds returns are more likely to be different than its benchmark NIFTY 500 returns, as Funds portfolio is significantly different.

Tata India Pharma & Healthcare Fund - Growth - Direct Plan fund’s expense ratio is 0.74%

The process for redemption is

  • Give a request for redemption of the number of units or the amount you want. The request will be acknowledged.
  • You will get information about the redemption and the NAV at which redeemed.
  • The amount will be deposited in the designated bank account.

The AUM of Tata India Pharma & Healthcare Fund - Growth - Direct Plan is currently ₹1,104 Crores.

The Top three stocks are Sun Pharma Inds., Dr. Reddys Lab and Aurobindo Pharma and account for 26% of its portfolio. Top 5 and 10 stocks of fund account for 38% and 59% of fund’s portfolio respectively.

Top three sectors of Tata India Pharma & Healthcare Fund - Growth - Direct Plan fund are Healthcare, Miscellaneous and Chemicals accounting for 99% of the total portfolio.

Funds Portfolio Quality is Somewhat Good. It has a large proportion of Green and Orange Stocks.Since this is a Equity - Sectoral Fund - Pharma & Health Care it is comparatively safer to invest in this fund. However, since it has not consistently outperformed its benchmark index on an average 3-year rolling returns basis it is not the most suitable fund for SIP.

The category of Tata India Pharma & Healthcare Fund - Growth - Direct Plan Fund is Equity - Sectoral Fund - Pharma & Health Care.

Meeta Shetty and Rajat Srivastava manage the Tata India Pharma & Healthcare Fund - Growth - Direct Plan Fund.

Tata India Pharma & Healthcare Fund - Growth - Direct Plan current PE ratio is 41.53 and PB ratio is 5.64

The asset allocation of Tata India Pharma & Healthcare Fund - Growth - Direct Plan is Stocks : 98.05%, Debt : 1.94% and Gold : 0%

The minimum SIP amount for Tata India Pharma & Healthcare Fund - Growth - Direct Plan is ₹100.00 and minimum lumpsum is ₹5000.00

The exit load for Tata India Pharma & Healthcare Fund - Growth - Direct Plan is 0.25% on or before 30 days

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...